Clearer guidelines expected for drug labels

03/28/2005 | Boston Globe (tiered subscription model), The

The FDA estimates current obtuse labels on prescription drugs are leading to $3.8 billion in unnecessary hospital costs because of incorrect drug use, one of several reasons behind the agency's work on guidelines it hopes will lead to labels that are clearer to physicians and consumers. The agency expects to issue the guidelines within weeks as part of an effort to ensure all parties better understand the text on a container of medicine and the paperwork that accompanies it.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX